發(fā)布時間：2019-01-14 09:50

【摘要】：目的評價子宮動脈灌注化療栓塞術(UACE)和子宮動脈栓塞術(UAE)后清宮治療剖宮產(chǎn)瘢痕妊娠(CSP)的療效。方法經(jīng)臨床確診CSP患者79例,根據(jù)不同介入方法隨機分為兩組,UACE組(A組)43例,UAE組(B組)36例,每組再根據(jù)CSP類型分為內(nèi)生型和外生型2個亞組,介入治療后行清宮術。以清宮術中出血量、人絨毛膜促性腺激素(HCG)恢復正常時間、二次治療率、治療成功率作為療效評估參數(shù),比較兩組間、亞組間相關數(shù)據(jù)的差異。結果兩組介入治療后清宮手術均順利,無子宮切除。兩組HCG恢復正常時間、并發(fā)癥發(fā)生情況、二次治療率比較差異有統(tǒng)計學意義(P0.05)。A組內(nèi)生型28例,B組25例,治療成功率分別為100%(28/28)和96.0%(24/25)(P0.05);A組外生型15例,B組11例,治療成功率分別為86.7%(13/15)和45.5%(5/11)(P0.05)。兩組外生型患者術后陰道持續(xù)出血時間、月經(jīng)復潮時間、HCG恢復正常時間、二次治療率及治療成功率差異均有統(tǒng)計學意義(P0.05)。結論UAE或UACE后清宮均為治療CSP的安全有效方法。內(nèi)生型CSP可考慮UAE,外生型CSP宜采用UACE。
[Abstract]:Objective to evaluate the efficacy of uterine artery infusion chemoembolization (UACE) and uterine artery embolization (UAE) in the treatment of cesarean scar pregnancy with (CSP). Methods Seventy-nine patients with CSP were randomly divided into two groups according to different interventional methods: UACE group (group A, 43 cases) and UAE group (group B, 36 cases). Each group was further divided into two subgroups according to CSP type: endogenous type and exogenous type. After interventional therapy, the uterus was cleared. The blood loss, the time of recovery of human chorionic gonadotropin (HCG), the rate of secondary treatment and the success rate of treatment were used as parameters to evaluate the curative effect. Results after interventional therapy, the operation was smooth and no hysterectomy was found. There were significant differences in the recovery time of HCG, the occurrence of complications and the rate of secondary treatment between the two groups (P0.05). There were 28 cases of endogenous type in). A group, 25 cases in group B, and 2 cases in group B, respectively. The success rate was 100% (28 / 28) and 96.0% (24 / 25) respectively (P0.05). The success rate of treatment was 86.7% (13 / 15) in group A and 45.5% (5 / 11) in group B (P0.05). There were significant differences between the two groups in the time of continuous vaginal bleeding, menorrhagia time, HCG recovery time, the rate of secondary treatment and the success rate of treatment (P0.05). Conclusion clearing the uterus after UAE or UACE is a safe and effective method for the treatment of CSP. Endogenous CSP can consider UAE, exogenous CSP should adopt UACE.
【作者單位】： 南方醫(yī)科大學附屬深圳市婦幼保健院放射科;南方醫(yī)科大學附屬深圳市婦幼保健院婦科;
【分類號】：R714.22

【參考文獻】

相關期刊論文 前4條

1 顧偉瑾;王海云;萬軍;張磊;王穎;王瑋;季芳;紀莉華;;不同劑量MTX經(jīng)動脈灌注治療切口妊娠療效的分析[J];介入放射學雜志;2010年07期

2 周慷;李曉光;金征宇;張曉波;石海峰;孫昊;王志偉;;清宮術前子宮動脈化療栓塞術治療瘢痕妊娠的療效分析[J];介入放射學雜志;2012年03期

3 陳毅;謝春明;楊敏玲;馮對平;龐寧東;崔麗萍;崔金喜;劉文英;;子宮動脈栓塞術在剖宮產(chǎn)術后子宮瘢痕妊娠治療中的應用[J];介入放射學雜志;2012年05期

4 曹滿瑞;何健龍;劉炳光;杜牧;朱志軍;;剖宮產(chǎn)疤痕妊娠的子宮動脈栓塞并清宮治療[J];臨床放射學雜志;2009年04期

【共引文獻】

相關期刊論文 前10條

1 胡喬飛;李堅;;子宮下段剖宮產(chǎn)切口瘢痕妊娠的臨床診療進展[J];當代醫(yī)學;2011年29期

2 鐘文新;曾志斌;明建中;沈比先;楚二偉;;經(jīng)子宮動脈途徑介入治療子宮切口妊娠的效果觀察[J];當代醫(yī)學;2012年21期

3 馬奔;曾北藍;陳春林;劉萍;張浩;;子宮動脈灌注化療栓塞聯(lián)合清宮術治療子宮瘢痕妊娠的臨床分析[J];婦產(chǎn)與遺傳(電子版);2012年02期

4 蘇站勤;高雪梅;;剖宮產(chǎn)瘢痕妊娠研究現(xiàn)狀及治療進展[J];中國婦產(chǎn)科臨床雜志;2012年06期

5 柯雁飛;張桂麗;石華;張菊梅;;子宮動脈栓塞和甲氨蝶呤注射在疤痕妊娠中的療效[J];貴陽醫(yī)學院學報;2013年05期

6 陳向東;柳曉春;陳麗婷;肇麗杰;yぜ嵫，

本文編號：2408579